Statistical methods in recent HIV noninferiority trials: reanalysis of 11 trials.
<h4>Background</h4>In recent years the "noninferiority" trial has emerged as the new standard design for HIV drug development among antiretroviral patients often with a primary endpoint based on the difference in success rates between the two treatment groups. Different statist...
Main Author: | Philippe Flandre |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21915255/pdf/?tool=EBI |
Similar Items
-
Noninferiority trials
by: Snapinn Steven M
Published: (2000-07-01) -
Understanding noninferiority trials
by: Seokyung Hahn
Published: (2012-11-01) -
Analyzing noninferiority trials: it is time for advantage deficit assessment – an observational study of published noninferiority trials
by: Gladstone BP, et al.
Published: (2015-01-01) -
Understanding superiority, noninferiority, and equivalence for clinical trials
by: Kamal Kishore, et al.
Published: (2020-01-01) -
A critical analysis of the noninferiority design of the TALENT trial
by: S. Saha, et al.
Published: (2020-01-01)